Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Streptococcus pneumoniae: Invasion and Inflammation.

Loughran AJ, Orihuela CJ, Tuomanen EI.

Microbiol Spectr. 2019 Mar;7(2). doi: 10.1128/microbiolspec.GPP3-0004-2018. Review.

2.

IgG1+ B-cell immunity predates IgE responses in epicutaneous sensitization to foods.

Jiménez-Saiz R, Ellenbogen Y, Koenig JFE, Gordon ME, Walker TD, Rosace D, Spill P, Bruton K, Kong J, Monteiro K, Wen J, Tuomanen EI, Kolbeck R, Chu DK, Waserman S, Jordana M.

Allergy. 2019 Jan;74(1):165-175. doi: 10.1111/all.13481. Epub 2018 Oct 11.

PMID:
29790165
3.

Pneumococcal neuraminidase activates TGF-β signalling.

Gratz N, Loh LN, Mann B, Gao G, Carter R, Rosch J, Tuomanen EI.

Microbiology. 2017 Jul 28. doi: 10.1099/mic.0.000511. [Epub ahead of print]

4.

RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host.

Honsa ES, Cooper VS, Mhaissen MN, Frank M, Shaker J, Iverson A, Rubnitz J, Hayden RT, Lee RE, Rock CO, Tuomanen EI, Wolf J, Rosch JW.

MBio. 2017 Jan 3;8(1). pii: e02124-16. doi: 10.1128/mBio.02124-16.

6.

Exogenous remodeling of lung resident macrophages protects against infectious consequences of bone marrow-suppressive chemotherapy.

Kamei A, Gao G, Neale G, Loh LN, Vogel P, Thomas PG, Tuomanen EI, Murray PJ.

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6153-E6161. Epub 2016 Sep 26.

7.

Bacterial Peptidoglycan Traverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior.

Humann J, Mann B, Gao G, Moresco P, Ramahi J, Loh LN, Farr A, Hu Y, Durick-Eder K, Fillon SA, Smeyne RJ, Tuomanen EI.

Cell Host Microbe. 2016 Jun 8;19(6):901. doi: 10.1016/j.chom.2016.05.017. No abstract available.

8.

Bacterial Peptidoglycan Traverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior

Humann J, Mann B, Gao G, Moresco P, Ramahi J, Loh LN, Farr A, Hu Y, Durick-Eder K, Fillon SA, Smeyne RJ, Tuomanen EI.

Cell Host Microbe. 2016 Mar 9;19(3):388-99. doi: 10.1016/j.chom.2016.02.009. Erratum in: Cell Host Microbe. 2016 Jun 8;19(6):901.

9.

Dynamic capsule restructuring by the main pneumococcal autolysin LytA in response to the epithelium.

Kietzman CC, Gao G, Mann B, Myers L, Tuomanen EI.

Nat Commun. 2016 Feb 29;7:10859. doi: 10.1038/ncomms10859.

10.

AdcAII of Streptococcus pneumoniae Affects Pneumococcal Invasiveness.

Brown LR, Gunnell SM, Cassella AN, Keller LE, Scherkenbach LA, Mann B, Brown MW, Hill R, Fitzkee NC, Rosch JW, Tuomanen EI, Thornton JA.

PLoS One. 2016 Jan 11;11(1):e0146785. doi: 10.1371/journal.pone.0146785. eCollection 2016.

11.

Host-pathogen interactions in bacterial meningitis.

Doran KS, Fulde M, Gratz N, Kim BJ, Nau R, Prasadarao N, Schubert-Unkmeir A, Tuomanen EI, Valentin-Weigand P.

Acta Neuropathol. 2016 Feb;131(2):185-209. doi: 10.1007/s00401-015-1531-z. Epub 2016 Jan 7. Review.

12.

Blood borne: bacterial components in mother's blood influence fetal development.

Loughran AJ, Tuomanen EI.

Inflamm Cell Signal. 2016;3(4). pii: e1421. doi: 10.14800/ics.1421.

13.

Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.

Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J, Alderson M, Tate A, Hollingshead SK, Tweten RK, Briles DE, Tuomanen EI, Paton JC.

Clin Vaccine Immunol. 2015 Oct;22(10):1079-89. doi: 10.1128/CVI.00293-15. Epub 2015 Aug 5.

14.

Correlation Between the Interval of Influenza Virus Infectivity and Results of Diagnostic Assays in a Ferret Model.

Inagaki K, Song MS, Crumpton JC, DeBeauchamp J, Jeevan T, Tuomanen EI, Webby RJ, Hakim H.

J Infect Dis. 2016 Feb 1;213(3):407-10. doi: 10.1093/infdis/jiv331. Epub 2015 Jun 11.

15.

Unencapsulated Streptococcus pneumoniae from conjunctivitis encode variant traits and belong to a distinct phylogenetic cluster.

Valentino MD, McGuire AM, Rosch JW, Bispo PJ, Burnham C, Sanfilippo CM, Carter RA, Zegans ME, Beall B, Earl AM, Tuomanen EI, Morris TW, Haas W, Gilmore MS.

Nat Commun. 2014 Nov 12;5:5411. doi: 10.1038/ncomms6411.

16.

Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function.

Brown AO, Mann B, Gao G, Hankins JS, Humann J, Giardina J, Faverio P, Restrepo MI, Halade GV, Mortensen EM, Lindsey ML, Hanes M, Happel KI, Nelson S, Bagby GJ, Lorent JA, Cardinal P, Granados R, Esteban A, LeSaux CJ, Tuomanen EI, Orihuela CJ.

PLoS Pathog. 2014 Sep 18;10(9):e1004383. doi: 10.1371/journal.ppat.1004383. eCollection 2014 Sep.

17.

Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.

Carter R, Wolf J, van Opijnen T, Muller M, Obert C, Burnham C, Mann B, Li Y, Hayden RT, Pestina T, Persons D, Camilli A, Flynn PM, Tuomanen EI, Rosch JW.

Cell Host Microbe. 2014 May 14;15(5):587-599. doi: 10.1016/j.chom.2014.04.005.

18.

A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media.

Rosch JW, Iverson AR, Humann J, Mann B, Gao G, Vogel P, Mina M, Murrah KA, Perez AC, Edward Swords W, Tuomanen EI, McCullers JA.

EMBO Mol Med. 2014 Jan;6(1):141-54. doi: 10.1002/emmm.201202150.

19.

Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.

Mann B, Thornton J, Heath R, Wade KR, Tweten RK, Gao G, El Kasmi K, Jordan JB, Mitrea DM, Kriwacki R, Maisonneuve J, Alderson M, Tuomanen EI.

J Infect Dis. 2014 Apr 1;209(7):1116-25. doi: 10.1093/infdis/jit502. Epub 2013 Sep 16.

20.

The pneumococcus: epidemiology, microbiology, and pathogenesis.

Henriques-Normark B, Tuomanen EI.

Cold Spring Harb Perspect Med. 2013 Jul 1;3(7). pii: a010215. doi: 10.1101/cshperspect.a010215. Review.

21.

Control of virulence by small RNAs in Streptococcus pneumoniae.

Mann B, van Opijnen T, Wang J, Obert C, Wang YD, Carter R, McGoldrick DJ, Ridout G, Camilli A, Tuomanen EI, Rosch JW.

PLoS Pathog. 2012;8(7):e1002788. doi: 10.1371/journal.ppat.1002788. Epub 2012 Jul 12.

22.

Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin.

Lebensburger JD, Howard T, Hu Y, Pestina TI, Gao G, Johnson M, Zakharenko SS, Ware RE, Tuomanen EI, Persons DA, Rosch JW.

Blood. 2012 Feb 23;119(8):1915-21. doi: 10.1182/blood-2011-08-374447. Epub 2011 Nov 30.

23.

Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza.

Karlström A, Heston SM, Boyd KL, Tuomanen EI, McCullers JA.

J Infect Dis. 2011 Nov;204(9):1358-66. doi: 10.1093/infdis/jir522. Epub 2011 Sep 7.

24.

The p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsis.

Garrison SP, Thornton JA, Häcker H, Webby R, Rehg JE, Parganas E, Zambetti GP, Tuomanen EI.

PLoS Pathog. 2010 Dec 23;6(12):e1001240. doi: 10.1371/journal.ppat.1001240.

25.

Pneumococcal pathogenesis: "innate invasion" yet organ-specific damage.

Thornton JA, Durick-Eder K, Tuomanen EI.

J Mol Med (Berl). 2010 Feb;88(2):103-7. doi: 10.1007/s00109-009-0578-5. Epub 2010 Feb 17. Review.

26.

Early biofilm formation on microtiter plates is not correlated with the invasive disease potential of Streptococcus pneumoniae.

Lizcano A, Chin T, Sauer K, Tuomanen EI, Orihuela CJ.

Microb Pathog. 2010 Mar-Apr;48(3-4):124-30. doi: 10.1016/j.micpath.2010.01.002. Epub 2010 Jan 22.

27.

Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease.

Rosch JW, Boyd AR, Hinojosa E, Pestina T, Hu Y, Persons DA, Orihuela CJ, Tuomanen EI.

J Clin Invest. 2010 Feb;120(2):627-35. doi: 10.1172/JCI39843. Epub 2010 Jan 19.

28.

Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.

Orihuela CJ, Mahdavi J, Thornton J, Mann B, Wooldridge KG, Abouseada N, Oldfield NJ, Self T, Ala'Aldeen DA, Tuomanen EI.

J Clin Invest. 2009 Jun;119(6):1638-46. doi: 10.1172/JCI36759. Epub 2009 May 11.

29.

Role of the manganese efflux system mntE for signalling and pathogenesis in Streptococcus pneumoniae.

Rosch JW, Gao G, Ridout G, Wang YD, Tuomanen EI.

Mol Microbiol. 2009 Apr;72(1):12-25. doi: 10.1111/j.1365-2958.2009.06638.x. Epub 2009 Feb 17.

30.

Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.

El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, Basaraba RJ, König T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA, Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ.

Nat Immunol. 2008 Dec;9(12):1399-406. doi: 10.1038/ni.1671. Epub 2008 Nov 2.

31.

Calcium efflux is essential for bacterial survival in the eukaryotic host.

Rosch JW, Sublett J, Gao G, Wang YD, Tuomanen EI.

Mol Microbiol. 2008 Oct;70(2):435-44. doi: 10.1111/j.1365-2958.2008.06425.x. Epub 2008 Aug 29.

32.

A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.

Leary PJ, Rajasekaran S, Morrison RR, Tuomanen EI, Chin TK, Hofmann PA.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2775-84. doi: 10.1152/ajpheart.00269.2008. Epub 2008 Apr 25.

33.

Planning and implementation of an infection control training program for healthcare providers in Latin America.

Caniza MA, Maron G, McCullers J, Clara WA, Cedillos R, Dueñas L, Arnold S, Williams BF, Tuomanen EI.

Infect Control Hosp Epidemiol. 2007 Dec;28(12):1328-33. Epub 2007 Oct 22.

PMID:
17994511
34.

Assessment of molecular typing methods to determine invasiveness and to differentiate clones of Streptococcus pneumoniae.

Obert CA, Gao G, Sublett J, Tuomanen EI, Orihuela CJ.

Infect Genet Evol. 2007 Dec;7(6):708-16. Epub 2007 Jul 27.

35.

Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity.

Weber JR, Tuomanen EI.

J Neuroimmunol. 2007 Mar;184(1-2):45-52. Epub 2007 Jan 8. Review.

PMID:
17210186
36.

Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients.

Obert CA, Miller ML, Montgomery J, Adamkiewicz T, Tuomanen EI.

Antimicrob Agents Chemother. 2007 Jan;51(1):386-9. Epub 2006 Oct 23.

37.

Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology.

Fillon S, Soulis K, Rajasekaran S, Benedict-Hamilton H, Radin JN, Orihuela CJ, El Kasmi KC, Murti G, Kaushal D, Gaber MW, Weber JR, Murray PJ, Tuomanen EI.

J Immunol. 2006 Nov 1;177(9):6182-91.

38.

Interplay of pneumococcal hydrogen peroxide and host-derived nitric oxide.

Hoffmann O, Zweigner J, Smith SH, Freyer D, Mahrhofer C, Dagand E, Tuomanen EI, Weber JR.

Infect Immun. 2006 Sep;74(9):5058-66.

39.

Identification of a Candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease.

Obert C, Sublett J, Kaushal D, Hinojosa E, Barton T, Tuomanen EI, Orihuela CJ.

Infect Immun. 2006 Aug;74(8):4766-77.

40.

Cell wall-mediated neuronal damage in early sepsis.

Orihuela CJ, Fillon S, Smith-Sielicki SH, El Kasmi KC, Gao G, Soulis K, Patil A, Murray PJ, Tuomanen EI.

Infect Immun. 2006 Jul;74(7):3783-9.

41.

beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae.

Radin JN, Orihuela CJ, Murti G, Guglielmo C, Murray PJ, Tuomanen EI.

Infect Immun. 2005 Dec;73(12):7827-35. Erratum in: Infect Immun. 2006 May;74(5):3078.

42.

Vancomycin stress response in a sensitive and a tolerant strain of Streptococcus pneumoniae.

Haas W, Kaushal D, Sublett J, Obert C, Tuomanen EI.

J Bacteriol. 2005 Dec;187(23):8205-10.

43.

Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia.

Yende S, Tuomanen EI, Wunderink R, Kanaya A, Newman AB, Harris T, de Rekeneire N, Kritchevsky SB.

Am J Respir Crit Care Med. 2005 Dec 1;172(11):1440-6. Epub 2005 Sep 15.

44.

Revising the role of the pneumococcal vex-vncRS locus in vancomycin tolerance.

Haas W, Sublett J, Kaushal D, Tuomanen EI.

J Bacteriol. 2004 Dec;186(24):8463-71.

45.

Dual phases of apoptosis in pneumococcal meningitis.

Mitchell L, Smith SH, Braun JS, Herzog KH, Weber JR, Tuomanen EI.

J Infect Dis. 2004 Dec 1;190(11):2039-46. Epub 2004 Nov 3.

PMID:
15529270
46.

Tissue-specific contributions of pneumococcal virulence factors to pathogenesis.

Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI.

J Infect Dis. 2004 Nov 1;190(9):1661-9. Epub 2004 Sep 21.

PMID:
15478073
47.

Microarray analysis of pneumococcal gene expression during invasive disease.

Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D, Tuomanen EI.

Infect Immun. 2004 Oct;72(10):5582-96.

48.

Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact.

Rodriguez CA, Atkinson R, Bitar W, Whitney CG, Edwards KM, Mitchell L, Li J, Sublett J, Li CS, Liu T, Chesney PJ, Tuomanen EI.

J Infect Dis. 2004 Oct 15;190(8):1481-7. Epub 2004 Sep 9.

PMID:
15378442
49.

Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain.

Zweigner J, Jackowski S, Smith SH, Van Der Merwe M, Weber JR, Tuomanen EI.

J Exp Med. 2004 Jul 5;200(1):99-106.

50.

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

Webby RJ, Perez DR, Coleman JS, Guan Y, Knight JH, Govorkova EA, McClain-Moss LR, Peiris JS, Rehg JE, Tuomanen EI, Webster RG.

Lancet. 2004 Apr 3;363(9415):1099-103.

PMID:
15064027

Supplemental Content

Loading ...
Support Center